Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink

References

• Global Strategy for the Diagnosis. Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2016 [cited 2016 June]. Available from: http://goldcopd.org/.
   Google Scholar
• Landis SH, Muellerova H, Mannino DM, Menezes AM, Han MK, van der Molen T, et al. Continuing to confront COPD international patient survey: methods, COPD prevalence, and disease burden in 2012–2013. Int J Chron Obstruct Pulmon Dis. 2014;9:597–611. PMID:24944511.
   PubMed Web of Science ®Google Scholar
• Kessler R, Partridge MR, Miravitlles M, Cazzola M, Vogelmeier C, Leynaud D, et al. Symptom variability in patients with severe COPD: a pan-European crosssectional study. Eur Respir J. 2011;37(2):264–72. doi:10.1183/09031936.00051110. PMID:21115606.
   PubMed Web of Science ®Google Scholar
• Espinosa de los Monteros MJ, Pena C, Soto Hurtado EJ, Jareño J, Miravitlles M. Variability of respiratory symptoms in severe COPD. Arch Bronconeumol. 2012;48(1):3–7. doi:10.1016/j.arbr.2011.07.006. PMID:21944843.
   PubMed Web of Science ®Google Scholar
• Jones PW, Agusti AG. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(4):822–32. doi:10.1183/09031936.06.00145104. PMID:16585091.
   PubMed Web of Science ®Google Scholar
• Pascoe S, Locantore N, Dransfield MT, Barnes NC, Pavord ID. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015;3(6):435–42. doi:10.1016/S2213-2600(15)00106-X. PMID:25878028.
   PubMed Web of Science ®Google Scholar
• Pavord ID, Lettis S, Locantore N, Pascoe S, Jones PW, Wedzicha JA, et al. Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD. Thorax. 2016;71(2):118–25. doi:10.1136/thoraxjnl-2015-207021. PMID:26585525.
   PubMed Web of Science ®Google Scholar
• Siddiqui SH, Guasconi A, Vestbo J, Jones P, Agusti A, Paggiaro P, et al. Blood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(4):523–5. doi:10.1164/rccm.201502-0235LE. PMID:26051430.
   PubMed Web of Science ®Google Scholar
• Price D, Rigazio A, Postma D, Papi A, Guy B, Agusti A, et al. Blood eosinophilia and the number of exacerbations in COPD patients. Eur Respir J. 2014;44(suppl):abstr 4416.
   Google Scholar
• Vedel-Krogh S, Nielsen SF, Lange P, Vestbo J, Nordestgaard BG, et al. Blood Eosinophils and exacerbations in chronic obstructive pulmonary disease. The copenhagen general population study. Am J Respir Crit Care Med. 2016;193(9):965–74. doi:10.1164/rccm.201509-1869OC. PMID:26641631.
   PubMed Web of Science ®Google Scholar
• Strimbu K, Tavel A. What are biomarkers? Curr Opin HIV AIDS. 2010;5(6):463–6. doi:10.1097/COH.0b013e32833ed177. PMID:20978388.
   PubMed Web of Science ®Google Scholar
• Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, et al. Acute exacerbations of COPD: identification of biological clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662–71. doi:10.1164/rccm.201104-0597OC. PMID:21680942.
   PubMed Web of Science ®Google Scholar
• Bafadhel M, McKenna S, Terry S, Mistry V, Pancholi M, Venge P, et al. Blood eosinophil to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2012;186(1):48–55. doi:10.1164/rccm.201108-1553OC. PMID:22447964.
   PubMed Web of Science ®Google Scholar
• DiSantostefano RL, Hinds D, Van Le H, Barnes NC. Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort. Respir Med. 2016;112:88–96. doi:10.1016/j.rmed.2016.01.013. PMID:26872700.
   PubMed Web of Science ®Google Scholar
• Weir M, Zhao H, Han MK, et al. Eosinophils in chronic obstructive pulmonary disease, the SPIROMICS cohort. Am J Resp Crit Care Med. 2014;189:A5902.
   Google Scholar
• Singh D, Kolsum U, Brightling CE, Locantore N, Agusti A, Tal-Singer R, et al. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014;44(6):1697–700. doi:10.1183/09031936.00162414. PMID:25323230.
   PubMed Web of Science ®Google Scholar
• Zysman M, Deslee G, Caillaud D, Chanez P, Escamilla R, Court-Fortune I, et al. Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD. Int J COPD 2017;12:1819–24. doi:10.2147/COPD.S129787.
   Google Scholar
• Oshagbemi OA, Burden AM, Braeken DCW, Henskens Y, Wouters EFM, Driessen JHM, Maitland-van der Zee AH, de Vries F, Franssen FME. Stability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline counts. Am J Respir Crit Care Med. 2017;195(10):1402–4. doi:10.1164/rccm.201701-0009LE. PMID:28165763.
   PubMed Web of Science ®Google Scholar
• Song JH, Lee CH, Kim JW, Lee WY, Jung JY, Park JH, Jung KS, Yoo KH, Park YB, Kim DK. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:2455–64. doi:10.2147/COPD.S129321. PMID:28860740.
   PubMed Web of Science ®Google Scholar
• Tran T, Caspard H, Ward C, van de Merwe R. Distribution of blood eosinophil in COPD patients. Eur Respir J. 2014;44(suppl):abstr 4765.
   Google Scholar
• Landis SH, Suruki R, Hilton E, Compton C, Galwey NW. Stability of Blood eosinophil count in patients with COPD in the UK Clinical Practice Research Datalink. COPD 2017;14(4):382–8. doi:10.1080/15412555.2017.1313827. PMID:28569614.
   PubMedGoogle Scholar
• Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the medical research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–6. doi:10.1136/thx.54.7.581. PMID:10377201.
   PubMed Web of Science ®Google Scholar
• Rothnie KJ, Müllerová H, Goss H, Chandan J, Quint JK. Validity and interpretation of spirometry for patients in primary care. Thorax 2015;70(Suppl 3):A188–90. doi:10.1136/thoraxjnl-2015-207770.359.
   Web of Science ®Google Scholar
• Guder G, Brenner S, Angermann CE, et al. GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study. Respir Res. 2012;13:13. doi:10.1186/1465-9921-13-13. PMID:22309369.
   PubMed Web of Science ®Google Scholar
• Müllerová H, Lu C, Li H, Tabberer M. Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care. PLoS One. 2014;9(1):e85540. doi:10.1371/journal.pone.0085540. PMID:24427316.
   PubMed Web of Science ®Google Scholar